Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M; Parkinson Study Group.

Arch Neurol. 2002 Oct;59(10):1541-50.

PMID:
12374491
2.

Coenzyme Q10 for Parkinson's disease.

Liu J, Wang L, Zhan SY, Xia Y.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008150. doi: 10.1002/14651858.CD008150.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD008150.

PMID:
22161420
3.

Does levodopa slow or hasten the rate of progression of Parkinson's disease?

Fahn S; Parkinson Study Group.

J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. Review.

PMID:
16222436
4.

WITHDRAWN: Coenzyme Q10 for Parkinson's disease.

Liu J, Wang LN, Zhan SY, Xia Y.

Cochrane Database Syst Rev. 2012 May 16;(5):CD008150. doi: 10.1002/14651858.CD008150.pub3. Review.

PMID:
22592726
5.

A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.

Shults CW, Haas RH, Beal MF.

Biofactors. 1999;9(2-4):267-72. Review.

PMID:
10416040
6.

Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.

Negida A, Menshawy A, El Ashal G, Elfouly Y, Hani Y, Hegazy Y, El Ghonimy S, Fouda S, Rashad Y.

CNS Neurol Disord Drug Targets. 2016;15(1):45-53. Review.

PMID:
26553164
7.
8.

[Coenzyme Q10--its importance, properties and use in nutrition and cosmetics].

Hojerov√° J.

Ceska Slov Farm. 2000 May;49(3):119-23. Review. Slovak.

PMID:
10953455
9.

The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.

Zhu ZG, Sun MX, Zhang WL, Wang WW, Jin YM, Xie CL.

Neurol Sci. 2017 Feb;38(2):215-224. doi: 10.1007/s10072-016-2757-9. Epub 2016 Nov 9. Review.

PMID:
27830343
10.

[Coenzyme Q10 (ubiquinone) in the treatment of heart failure. Are any positive effects documented?].

Spigset O.

Tidsskr Nor Laegeforen. 1994 Mar 20;114(8):939-42. Review. Norwegian.

PMID:
8191473
11.

Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone).

Mortensen SA.

Clin Investig. 1993;71(8 Suppl):S116-23. Review.

PMID:
8241694
12.

Coenzyme Q10.

Pepping J.

Am J Health Syst Pharm. 1999 Mar 15;56(6):519-21. Review. No abstract available.

PMID:
10192685
13.

Coenzyme Q10 as a possible treatment for neurodegenerative diseases.

Beal MF.

Free Radic Res. 2002 Apr;36(4):455-60. Review.

PMID:
12069110
14.

[Coenzyme Q10: biochemistry, pathophysiology of its deficiency and potential benefit of an increased intake].

Malchair P, Van Overmeire L, Boland A, Salmon E, Pierard L, Seutin V.

Rev Med Liege. 2005 Jan;60(1):45-51. Review. French.

15.

Coenzyme Q10 in health and disease.

Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA, Stender S.

Eur J Clin Nutr. 1999 Oct;53(10):764-70. Review.

PMID:
10556981
16.

Creatine and coenzyme Q10 in the treatment of ALS.

Strong MJ, Pattee GL.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1 Suppl 4:17-20. Review. No abstract available.

PMID:
11466954
17.

Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade.

Kerr DS.

Mol Genet Metab. 2010 Mar;99(3):246-55. doi: 10.1016/j.ymgme.2009.11.005. Epub 2009 Nov 26. Review.

PMID:
20060349
18.
19.

Coenzyme Q-10: efficacy, safety, and use.

Jones K, Hughes K, Mischley L, McKenna DJ.

Altern Ther Health Med. 2002 May-Jun;8(3):42-55; quiz 56, 138. Review. No abstract available.

PMID:
12017500
20.

Drug treatment effects on disease progression.

Chan PL, Holford NH.

Annu Rev Pharmacol Toxicol. 2001;41:625-59. Review.

PMID:
11264471

Supplemental Content

Support Center